Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Biol Chem ; 281(35): 25215-22, 2006 Sep 01.
Article in English | MEDLINE | ID: mdl-16818494

ABSTRACT

The stress-activated c-Jun N-terminal protein kinase (JNK) and p38 mitogen-activated protein (MAP) kinase (p38) regulate apoptosis induced by several forms of cellular insults. Potential targets for these kinases include members of the Bcl-2 family proteins, which mediate apoptosis generated through the mitochondria-initiated, intrinsic cell death pathway. Indeed, the activities of several Bcl-2 family proteins, both pro- and anti-apoptotic, are controlled by JNK phosphorylation. For example, the pro-apoptotic activity of Bim(EL), a member of the Bcl-2 family, is stimulated by JNK phosphorylation at Ser-65. In contrast, there is no reported evidence that p38-induced apoptosis is due to direct phosphorylation of Bcl-2 family proteins. Here we report evidence that sodium arsenite-induced apoptosis in PC12 cells may be due to direct phosphorylation of Bim(EL) at Ser-65 by p38. This conclusion is supported by data showing that ectopic expression of a wild type, but not a non-phosphorylatable S65A mutant of Bim(EL), potentiates sodium arsenite-induced apoptosis and by experiments showing direct phosphorylation of Bim(EL) at Ser-65 by p38 in vitro. Furthermore, sodium arsenite induced Bim(EL) phosphorylation at Ser-65, which was blocked by p38 inhibition. This study provides the first example whereby p38 induces apoptosis by phosphorylating a member of the Bcl-2 family and illustrates that phosphorylation of Bim(EL) on Ser-65 may be a common regulatory point for cell death induced by both JNK and p38 pathways.


Subject(s)
Apoptosis Regulatory Proteins/chemistry , Apoptosis , Membrane Proteins/chemistry , Proto-Oncogene Proteins/chemistry , p38 Mitogen-Activated Protein Kinases/physiology , Animals , Apoptosis Regulatory Proteins/metabolism , Arsenites/pharmacology , Bcl-2-Like Protein 11 , Cell Survival , Enzyme Inhibitors/pharmacology , Membrane Proteins/metabolism , Oxidative Stress , PC12 Cells , Phosphorylation , Protein Structure, Tertiary , Proto-Oncogene Proteins/metabolism , Rats , Serine/chemistry , Sodium Compounds/pharmacology , Transfection , p38 Mitogen-Activated Protein Kinases/metabolism
2.
J Neurosci ; 24(9): 2277-85, 2004 Mar 03.
Article in English | MEDLINE | ID: mdl-14999078

ABSTRACT

Recent studies indicate that neuroprotection afforded by brain-derived neurotrophic factor (BDNF) is mediated by extracellular signal-regulated kinase (ERK) and phosphatidylinositol-3 kinase (PI3K). However, the mechanisms by which ERK and PI3K exert neuroprotection are not completely understood. Because ERK1/2 and PI3K both stimulate serum response element (SRE)-mediated gene expression, and serum response factor (SRF) is indispensable for SRE-mediated transcription, we investigated whether SRF contributes to ERK1/2 and PI3K neuroprotection. To accomplish this goal, we used an established experimental paradigm in which BDNF protects postnatal cortical neurons against both trophic deprivation and camptothecin-induced DNA damage. BDNF protection against camptothecin is mediated primarily by ERK1/2 activation, whereas its protection against trophic deprivation is mainly through stimulation of the PI3K pathway (Hetman et al., 1999). Here we demonstrate that expression of a wild-type SRF is sufficient to protect postnatal cortical neurons against camptothecin or trophic deprivation. Expression of a dominant-negative SRF partially reversed BDNF neuroprotection against both apoptotic insults. Moreover, the dominant-negative SRF inhibited neuroprotection against trophic withdrawal afforded by expression of a constitutive active PI3K. In addition, protection against camptothecin by expression of constitutive active mitogen-activated protein kinase kinase 1, an upstream kinase that activates ERK1/2, was also blocked by expression of the dominant-negative SRF. These data suggest that SRF is both necessary and sufficient for BDNF neuroprotection of cortical neurons against trophic deprivation and DNA damage. Our data provide a direct demonstration of a biological function of SRF in neurons and a novel downstream neuroprotective mechanism common to both ERK1/2 and PI3K pathways.


Subject(s)
Neurons/metabolism , Serum Response Factor/physiology , Animals , Brain-Derived Neurotrophic Factor/pharmacology , Camptothecin/antagonists & inhibitors , Camptothecin/pharmacology , Cell Survival/drug effects , Cell Survival/physiology , Cells, Cultured , DNA Damage/physiology , Enzyme Activation/drug effects , Gene Expression , Genes, Dominant , MAP Kinase Kinase 1 , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3 , Mitogen-Activated Protein Kinase Kinases/biosynthesis , Mitogen-Activated Protein Kinase Kinases/genetics , Mitogen-Activated Protein Kinases/metabolism , Nerve Growth Factors/pharmacology , Neurons/cytology , Neurons/drug effects , Neuroprotective Agents/pharmacology , Phosphatidylinositol 3-Kinases/drug effects , Phosphatidylinositol 3-Kinases/genetics , Phosphatidylinositol 3-Kinases/metabolism , Rats , Rats, Sprague-Dawley , Serum Response Factor/biosynthesis , Serum Response Factor/genetics , Signal Transduction/physiology , Transfection
3.
Toxicol Sci ; 79(1): 137-46, 2004 May.
Article in English | MEDLINE | ID: mdl-14976342

ABSTRACT

Rotenone is a naturally derived pesticide that has recently been shown to evoke the behavioral and pathological symptoms of Parkinson's disease in animal models. Though rotenone is known to be an inhibitor of the mitochondrial complex I electron transport chain, little is known about downstream pathways leading to its toxicity. We used human dopaminergic SH-SY5Y cells to study mechanisms of rotenone-induced neuronal cell death. Our results suggest that rotenone, at nanomolar concentrations, induces apoptosis in SH-SY5Y cells that is caspase-dependent. Furthermore, rotenone treatment induces phosphorylation of c-Jun, the c-Jun N-terminal protein kinase (JNK), and the p38 mitogen activated protein (MAP) kinase, indicative of activation of the p38 and JNK pathways. Importantly, expression of dominant interfering constructs of the JNK or p38 pathways attenuated rotenone-induced apoptosis. These data suggest that rotenone induces apoptosis in the dopaminergic SH-SY5Y cells that requires activation of the JNK and p38 MAP kinases and caspases. These studies provide insights concerning the molecular mechanisms of rotenone-induced apoptosis in neuronal cells.


Subject(s)
Apoptosis/drug effects , Receptors, Dopamine/drug effects , Rotenone/toxicity , p38 Mitogen-Activated Protein Kinases/adverse effects , Caspases/adverse effects , Caspases/drug effects , Caspases/metabolism , Cell Line, Tumor , Chlorpyrifos/toxicity , Humans , JNK Mitogen-Activated Protein Kinases/adverse effects , JNK Mitogen-Activated Protein Kinases/drug effects , JNK Mitogen-Activated Protein Kinases/metabolism , MAP Kinase Kinase 4 , Mitogen-Activated Protein Kinase Kinases/adverse effects , Mitogen-Activated Protein Kinase Kinases/drug effects , Mitogen-Activated Protein Kinase Kinases/metabolism , Receptors, Dopamine/genetics , Receptors, Dopamine/metabolism , Rotenone/chemistry , Signal Transduction/drug effects , Transfection/methods , p38 Mitogen-Activated Protein Kinases/drug effects , p38 Mitogen-Activated Protein Kinases/metabolism
4.
Exp Cell Res ; 277(1): 15-30, 2002 Jul 01.
Article in English | MEDLINE | ID: mdl-12061814

ABSTRACT

Inhibitors of transcription and translation can protect cells from physiological cell deaths induced by a variety of stimuli. These observations have been taken to suggest that de novo macromolecular synthesis may be an essential component of the cell death process. Paradoxically, the same inhibitors, at higher concentrations, themselves trigger the death of cells. Previously, we have mapped a conserved and ordered sequence of events that exerts physiological cell death. Diverse signals converge to activate this lethal pathway, composed of a proteolytic cascade of caspases and subsequent cyclin-dependent kinases. Here we report that inhibitors of nuclear gene expression, when they block cell death, act upstream of this lethal process to prevent its activation. In contrast, when cell death is triggered by high doses of the inhibitors, these same essential molecules are activated, despite the essentially complete blockade of macromolecular synthesis. This inhibitor-induced death response is associated with the release of cytochrome c from mitochondria and the activation of apical caspase 9 and is blocked by overexpression of Bcl-2. These data demonstrate that all essential molecules that exert lethality already are resident within cells and are activated posttranslationally upon stimulation. De novo macromolecular synthesis pertains idiosyncratically only to upstream, modulatory elements of particular death responses.


Subject(s)
Apoptosis , CDC2-CDC28 Kinases , Protein Biosynthesis , Protein Processing, Post-Translational , RNA/biosynthesis , Caspase 9 , Caspases/metabolism , Cyclin A/metabolism , Cyclin-Dependent Kinase 2 , Cyclin-Dependent Kinases/metabolism , Cycloheximide/pharmacology , Cytochrome c Group/metabolism , Dactinomycin/pharmacology , Dexamethasone/pharmacology , Dose-Response Relationship, Drug , Glucocorticoids/pharmacology , HeLa Cells , Humans , Macromolecular Substances , Mitochondria/drug effects , Protein Serine-Threonine Kinases/metabolism , Protein Synthesis Inhibitors/pharmacology , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...